Meet Our Featured Speakers
benefits
PHARMA OMICS & AI 2026 delivers market intelligence and industry insights on the latest applications of AI, ML, and omics in drug development and bioprocessing technologies.
Benefits of attending include:
- Two days of focused presentations sharing the latest market insights, with an emphasis on exchanging real-world experiences and results from AI and machine learning deployments across drug discovery, development, and bioprocessing.
- An exclusive networking opportunity to connect with R&D experts, pharmaceutical leaders, data scientists, bioinformaticians, and biomanufacturing professionals addressing similar challenges in the rapidly evolving AI and omics landscape.
- Insights into regional research initiatives from U.S. biopharma experts and manufacturers, sharing experiences, recent findings, and next steps for applying AI, machine learning, and omics in the pharmaceutical sector.
- Technical presentations from solution providers and platform teams showcasing results from evaluations and pilot programs, highlighting technological advancements and new insights.
- New case studies showcasing end-to-end omics pipelines from industry experts involved in drug discovery and development programs.
- A unique opportunity to connect with industry leaders and explore new possibilities through insights into omics pipelines, bioprocessing, and data practices in the rapidly evolving life sciences landscape.
key takeaways
- Understand the current market dynamics of AI, machine learning, and omics in the pharmaceutical industry, and how they impact your organization
- Learn how to develop effective strategies for successful AI and omics initiatives, including multi-omics integration, across drug discovery, development, and manufacturing
- Hear the latest trends with an overview of the current year and projections for 2027, covering predictive modeling, computational biology, cross-omics integration, and the data platforms gaining momentum in the pharmaceutical industry
- Discuss recent innovations, emerging technologies, and new approaches that advance biomarker discovery, precision medicine, and clinical trial optimization
- Access diverse perspectives from pharmaceutical leaders, data scientists, bioinformaticians, and biomanufacturing experts, featuring regional insights and cross-industry learnings
who should attend?
This event is for pharmaceutical and biotechnology leaders, R&D and clinical teams, and data and operations professionals who apply AI, ML, and omics to advance discovery, enhance precision medicine, and streamline manufacturing.
Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:
Bioinformatics Software DevelopmentData Engineering & MLOps Multi-Omics Integration Biomanufacturing Data Platform Management News Reporting and Journalism Biomarker Development Data Science & AI Patient Recruitment Biomarker Discovery Drug Development Pipelines Precision Medicine Business Development Drug Discovery & Design Process Analytics Clinical Trial Management Legal and Regulations Regulatory Affairs Computational Biology Manufacturing Operations Research and Development Consulting & Advisory MSAT & Tech Transfer Sales and Marketing
they've attended our events
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.